Justin Kozak, Author at Founder Shield

Life Sciences Practice Lead

Justin has been involved in risk management for over a decade with Hub International, PBC, and Founder Shield. As EVP, he supports all new clients and partners joining the Founder Shield Network. Justin thrives in building bespoke insurance programs for emerging industries, especially in the Life Sciences space. His motto is to “let challenges be your driving force.”

Intellectual Property D&O Cyber Cryptocurrency Micromobility

Articles by Justin Kozak

April 16 • Risk Management

From Phase I to Market Access: A Lifecycle Approach to Life Sciences Risk Management

Modern life sciences risk management must evolve alongside innovation. From R&D to commercialization, learn how to protect your revenue and reputation by navigating clinical trial liabilities, shifting regulations, and the complexities of specialized insurance coverage.

Read Article

April 7 • Directors & Officers

Post-Assignment: What Happens to D&O Coverage When Your Company Undergoes an ABC?

An ABC offers a streamlined alternative to bankruptcy, but shifting fiduciary duties increases litigation risk. Protect personal assets by securing a funded D&O Tail policy before transferring assets to the assignee.

Read Article

October 8 • Risk Management

Beyond the Lawsuit: The Real Price of Pharma Regulatory and Compliance Failures

Prevent silent pharma regulatory and compliance failures—here’s how. Learn how proactive strategy and global oversight protect reputation and market access.

Read Article

September 24 • Growth

Beyond the Hype: How Biotech Startups Manage Risk for Real-World Drug Development

How biotech startups are overcoming challenges and achieving breakthroughs with savvy strategies, partnerships, and risk management.

Read Article

Authored FAQs by Justin Kozak

Justin Kozak

Life Sciences Practice Lead

Articles by Justin Kozak

From Phase I to Market Access: A Lifecycle Approach to Life Sciences Risk Management

Post-Assignment: What Happens to D&O Coverage When Your Company Undergoes an ABC?

Beyond the Lawsuit: The Real Price of Pharma Regulatory and Compliance Failures

Beyond the Hype: How Biotech Startups Manage Risk for Real-World Drug Development

Justin Kozak In the Media

The fastest path to AI: Why mid-market modernization starts with data, not replacement

Beyond the Cuts: Understanding the Real Risks for Biotech and Medical Research

Opinion: NIH Funding Cuts Are a Blow to Biotech

Fintech Meets Banking: Navigating the Risks and Rewards of Hybrid Finance

Authored FAQs by Justin Kozak

What Coverage Enhancements Are Common For Product Liability Insurance?

What Are Common Exclusions For a Product Liability Policy?

What Is Product Liability Insurance Rated On?

Authored Definitions